Nanoparticle-mediated Tolerance
Nanoparticle-Mediated Tolerance is a therapeutic strategy in immune tolerance induction that employs biocompatible nanoparticles to selectively deliver antigens or immunomodulatory agents to specific immune cells, thereby promoting antigen-specific immune unresponsiveness while minimizing systemic immunosuppression.
73
Publications
4.8K
Citations
480
Authors
177
Institutions
Publications per year
2017–2026
53
Parents
73
Tolerogenic nanoparticles inhibit T cell–mediated autoimmunity through SOCS2
Ada Yeste, Maisa C. Takenaka, Iván Mascanfroni et al. · Science Signaling · 2016 · 194 citations
1–5 of 73
480
10
h-index
10
h-index
5
h-index
4
h-index
4
h-index
1–5 of 480
177
Northwestern University
Evanston, United States
12 h-index
46 publications
5.2K citations
University of Michigan
Ann Arbor, United States
10 h-index
42 publications
2.7K citations
Harvard University
Cambridge, United States
5 h-index
13 publications
2.5K citations
Scripps Research Institute
San Diego, United States
4 h-index
18 publications
1.3K citations
University of California, Los Angeles
Los Angeles, United States
4 h-index
28 publications
2.2K citations

Boston Children's Hospital
Boston, United States
3 h-index
14 publications
637 citations
Selecta Biosciences (United States)
Watertown, United States
3 h-index
23 publications
5.7K citations
University of Chinese Academy of Sciences
Beijing, China
3 h-index
9 publications
525 citations
1–8 of 177
5 publications · 575 citations
5
h-index
5 publications · 224 citations
5
h-index
4 publications · 168 citations
4
h-index
3 publications · 144 citations
3
h-index
2 publications · 102 citations
2
h-index
1–5